EC Number   |
Title |
Organism |
|---|
   3.4.21.43 | Functional characterization of alternative and classical pathway C3/C5 convertase activity and inhibition using purified models |
Homo sapiens |
| 3.4.21.43 | The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models |
Homo sapiens |
| 3.4.21.43 | A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases |
Homo sapiens |
| 3.4.21.43 | A new function of the activated third component of complement: binding to C5, an essential step for C5 activation |
Homo sapiens |
| 3.4.21.43 | A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex |
Homo sapiens |
| 3.4.21.43 | Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement |
Homo sapiens |
| 3.4.21.43 | Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages |
Homo sapiens |
| 3.4.21.43 | Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro |
Mus musculus |
| 3.4.21.43 | Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway |
Homo sapiens |
| 3.4.21.43 | Dissecting the regions of virion-associated Kaposis sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding |
Homo sapiens |
